CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive: Intracellular signalling downstream of the chemotactic CXCL12-CXCR4 axis, responsible for disrupted homing in CML, has been elucidated in LSCs, highlighting novel therapeutic opportunities.